Quebec-based Quantum eMotion’s partner, Greybox Solutions, has produced successful results in testing its digital therapeutics platform (DTx) for heart failure patients. The study, in collaboration with several other partners, revealed a decrease in healthcare costs and hospital visits. Quantum eMotion’s CEO, Francis Bellido, highlighted the importance of robust cybersecurity in protecting patient data and praised Greybox’s partners for their contributions to the study.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
